A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2003

Primary Completion Date

January 31, 2005

Conditions
Haemophilia A
Interventions
BIOLOGICAL

Optivate® (Human Coagulation Factor VIII)

Trial Locations (5)

20-093

Children's Haematology and Oncology Clinic, Ul., W. Chodzki Str.

30-663

Academic Children's Hospital, Children's Haematology and Oncology, Clinic 265 Wielicka str., Krakow

61-825

Specialist Centre for Medical Care of Mother and Children, Internal Ward 1, 7/8 Dr B. Krysiewicza str., Poznan

00-576

Department of Paediatrics, Haematology and Oncology, Medical University of Warsaw, 24 Marszalkowska str., Warsaw

50-345

Children's Clinic for Bone Marrow Transplant, Oncology and Haematology, Medical University of Wroclaw, 44 Bujwida str., Wroclaw

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER